metabolomics

Researchers with the International Agency for Research on Cancer have published a prospective study analysing pre-diagnostic plasma metabolomics and the risk of triple-negative breast cancer within the European Prospective Investigation into Cancer and Nutrition (EPIC). The work examines whether metabolic signatures measured in blood before diagnosis are associated with later development of this aggressive breast cancer subtype. Details on the strength of the findings were not provided.

Technology Networks has published a feature explaining how recent analytical advances are allowing metabolomics to deliver more dependable biological insights. The piece examines improvements in analytical techniques used to profile metabolites, arguing that these developments reduce variability and strengthen the reliability of findings that link metabolic data to biological processes. The discussion is aimed at researchers working in the life sciences who rely on metabolomics data for their conclusions.